Our meeting is the place to learn about the latest international research across specialties in peripheral neuropathy. As the largest peripheral nerve meeting globally, it is the premier venue to connect with your peers.

Abstract Deadlines

The PNS has two submission deadlines for the 2024 Annual Meeting

Early Abstract Submission Deadline (Passed)
1 December 2023

Regular Abstract Deadline (Passed)
5 January 2024

Late-Breaking Abstract Deadline

14 May 2024 (23.59 CDT US/Canada)

Late-Breaking Abstract Submission Rules & Regulations

  • Abstracts must be novel or new;
  • No abstracts that have been published are permitted (in-press is acceptable).
  • Late-breaking abstracts will not have the opportunity to present a poster.
  • Limited oral presentation opportunities are available for selected abstracts.

All accepted abstracts will be included in the Annual Meeting mobile app. Accepted abstracts will be published in the Journal of the Peripheral Nervous System (JPNS) as submitted.

  • Abstracts previously presented may be submitted to the PNS. Please cite the meeting, location, and date of the previous presentation. Abstracts cannot be previously published.
  • The word limit for all abstracts is 300 words, NOT including the title and authors.
  • Presenting authors of accepted abstracts will be required to register for the meeting by 31 May 2024.
  • There can be one presenter per accepted abstract.
  • All presenting authors must stand by their poster(s) for their designated standby time. There will be no option to change the assigned standby time and poster session. Poster sessions will occur on Sunday and Monday of the meeting. There will be a designated poster viewing time on Tuesday (no standby times), but all attendees will be encouraged to visit the poster hall. Please make plans to attend the meeting in full.
  • Abstracts may not be submitted by mail or email.
  • All accepted abstracts submitted during the regular abstract submission period will be eligible for a poster presentation. Abstracts with the top scores will be invited to give a platform presentation (10-minute talk, followed by 5-minutes Q&A) in one of the meeting sessions and will not be presented in poster form. Abstracts selected for flash presentations (3-minute talk, followed by 2-minutes Q&A) in one of the meeting sessions are also required to present in poster form. Late-breaking abstracts will not have the opportunity to present a poster.

    Late-Breaking Abstracts

    Late-breaking abstract submission will be open from 1 May – 14 May 2024. Limited presentation opportunities are available. Late-breaking abstracts will not have the opportunity to present a poster. Late-breaking abstracts must be novel or new. No abstracts that have been published are permitted (in-press is acceptable). Notification of acceptance will be sent on or by 21 May 2024.

    Preparation of Your Abstract

    • No identifying features, such as names of hospitals, medical schools, clinics, or cities, may be listed in the title or text of the abstract. Do not include the names of any of the authors.  Authors’ names and affiliations (institutions) will be submitted online during the process.
    • Tables, graphs, and images are not permitted.
    • Avoid trade names whenever possible.
    • The title cannot be longer than (15) words but should indicate the nature of the study. Capitalize the first letter of each word within the title.  Avoid abbreviations whenever possible.
    • All abstracts must be submitted in US English.
    • Abstracts should state briefly the purpose (within the introduction), methods, results, and conclusions of the work. There is a strict 300-word limit (title and authors not included).
      • Clearly state the purpose of the abstract.
      • Describe your selection of observations or experimental subjects.
      • Present your results in a logical sequence.
      • Emphasize new and important aspects of the study and conclusions drawn from them.

    Changes to Your Abstract

    Should you wish to correct an abstract already submitted before the submission deadline of 5 January 2024, please complete this form. A PNS Executive Office staff member will unlock your submission so that you can make any changes. After the final submission deadline (5 January 2024), submitters can no longer modify or correct the abstract’s content, and the abstract will be published as submitted.

    Withdrawing an Abstract from the 2024 PNS Annual Meeting

    The PNS expects that all accepted abstracts will, under all usual circumstances, be presented in person at the meeting.  If the presenting author cannot present an abstract in person, you may add a substitute presenter. See “Substitute Presenters” on this page for details on how to do so.  Failure to present an accepted abstract may cause the author(s) to be ineligible for abstract submission at next year’s Annual Meeting.

    To request the withdrawal of an abstract, please submit an Abstract Withdrawal Request. Withdrawals will only be accepted via this form; emailed requests will not be accepted.

    The following information will be needed to complete your online abstract withdrawal request:

    • Presenting author’s first and last name
    • Email address
    • Abstract title
    • Reason for withdrawal

    Withdrawn abstracts will not be published in the Journal of the Peripheral Nervous System (JPNS).

    Request for Approval of Substitute Presenter

    Substitute presenters must be approved in advance. The request for approval of a substitute presenter must be submitted by the First Author at least 48 hours before the PNS Annual Meeting begins. Submit a Substitute Presenter Request here.

    Other notes:

    • Substitute presenters must be a co-author listed on the abstract, be qualified to discuss all aspects of the abstract during its presentation, and pay the registration fee to attend the Annual Meeting.
    • Email requests will not be accepted.
    • A co-author or colleague not pre-approved via the Substitute Presenter Approval Request Form will not be allowed to present the abstract on behalf of the First Author.

    Visa Information

    You will be presented with the option to designate your VISA requirement within your abstract submission. The PNS Scientific Program Committee will accord special attention to pre-reviewing these specific abstracts during the month of November. Upon the acceptance of your abstract, you will promptly receive an official VISA invitation letter from the PNS Executive Office. To access comprehensive guidance on the VISA application process, we invite you to explore further details here.

    Abstract Notification Dates

    Early Abstract Submission Notification

    Authors requiring a Visa will be notified of pre-acceptance by 11 December 2023

    Regular Abstract Submission Notification

    Authors will be notified of abstract acceptance by 27 February 2024

    Poster, Platform, and Flash Presentation Notification

    Authors will be notified of presentation status by 30 April 2024

    Late-Breaking Abstract Submission Notification

    Authors will be notified of abstract acceptance by 21 May 2024

    Selection of Abstracts

    The PNS Scientific Program Committee completes the abstract review process. As peers, they carefully review each abstract for content/consideration. The Editor-in-Chief of the JPNS is part of this peer review process and reviews the submission for publication.

    Publication Information

    Accepted abstracts will be published as a compilation in an abstract supplement of our Journal, the Journal of the Peripheral Nervous System (JPNS), under copyright by the Peripheral Nerve Society. The Society does not copyright individual abstracts; you can publish or present your work elsewhere.

    Abstract Embargo Policy

    The embargo for all abstracts at the upcoming 2024 PNS Annual Meeting is Friday, 14 June 2024 at 16.00 CT (US/Canada), which is the date and time all abstracts will be released in the meetings mobile app (registered attendees only). Information contained in those abstracts may not be released until the abstracts appear in the mobile app.

    Abstract Prize Criteria

    For ALL abstract prizes:

    The abstract presenter must be a current Junior Member of PNS (dues paid) when the abstract is submitted. Please click here for more information on PNS membership.

    The recipient is required to attend and present at the 2023 Annual Meeting.

    Arthur K. Asbury Prize: The abstract must pertain to GBS/CIDP/Inflammatory.

    Richard and Mary Bunge Prize: The abstract must pertain to nerve biology.

    Peter J. Dyck Prize: The abstract must pertain to diabetes.

    J.W. Griffin Prize: The abstract must pertain to regeneration.

    Anita Harding Prize: The presenting author must be female.

    Jonathan Pembroke Prize: The presenting author must be from Australia, New Zealand, or South Asia.

    P.K. Thomas Prize: The abstract must pertain to inherited neuropathies.

    Richard A.C. Hughes Prize: The abstract must pertain to clinical studies.

    In evaluating each presentation, the prize committee will consider the quality of the presentation, groundbreaking/innovative results, and the quality of the presenter.


    Connect with PNS Executive Office Staff at meetings@pnsociety.com with specific questions regarding the Annual Meeting.